Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies

Abstract

Patients with GAD-abs must be screened for an underlying cancer if they have clinical presentations different from those typically associated with this autoimmunity or develop classic PNS. The risk for cancer increases with age, male sex, and the presence of coexisting neuronal cell-surface antibodies.